Reg Waldeck possesses extensive experience in global market access, pricing, and health economics, most recently serving as Head of Global Market Access at Bayer from August 2017 to June 2024. Prior to Bayer, Reg Waldeck held several leadership roles at Celldex Therapeutics, including VP, Market Access Strategy Leader, and at Bristol-Myers Squibb, where positions included Executive Director of Global Market Access Capability Building. Reg Waldeck's academic credentials include a PostDoc in Biophysics from Caltech and a Certificate in Health Economics from Monash University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices